Senior insider sale
SVP Finance & CFO at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$17.85M
245.11K shares
What this filing means
HOUGEN ELIZABETH L plans to sell 245.11K shares of IONIS PHARMACEUTICALS INC valued at approximately $17.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001972481-26-000103
Officer· SVP Finance & CFO
Since Jul 2018
245.11K
Shares to sell
$17.85M
Approx. market value
225.20K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
1/2/2019
225.20KTotal acquired225.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2019 | Option Exercise Cash | 225.20K | — |
| Total | 225.20K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.99K
Market value
$580.0K
1/30/2026
—Completed
Units to sell
12.92K
Market value
$985.1K
1/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
225.20K
Market value
$16.28M
3/16/2026
Total
Units
245.11K
Value
$17.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/30/2026 | 6.99K | $580.0K | — | Completed |
1/16/2026 | 12.92K | $985.1K | — | Completed |
| Planned — Approximate Date | ||||
3/16/2026 | 225.20K | $16.28M | Nasdaq | Planned |
| Total | 245.11K | $17.85M | ||